Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1963 2
1964 1
1965 6
1966 24
1967 18
1968 19
1969 18
1970 30
1971 21
1972 29
1973 23
1974 22
1975 22
1976 22
1977 15
1978 24
1979 33
1980 37
1981 28
1982 26
1983 28
1984 34
1985 32
1986 36
1987 37
1988 34
1989 40
1990 19
1991 33
1992 29
1993 23
1994 31
1995 26
1996 17
1997 20
1998 35
1999 20
2000 24
2001 20
2002 20
2003 28
2004 26
2005 33
2006 40
2007 45
2008 37
2009 44
2010 39
2011 43
2012 51
2013 58
2014 65
2015 51
2016 65
2017 52
2018 61
2019 74
2020 61
2021 53
2022 57
2023 47
2024 32

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,895 results

Results by year

Filters applied: . Clear all
Page 1
The effect of vitamin D on the severity of dysmenorrhea and menstrual blood loss: a randomized clinical trial.
Amzajerdi A, Keshavarz M, Ghorbali E, Pezaro S, Sarvi F. Amzajerdi A, et al. BMC Womens Health. 2023 Mar 27;23(1):138. doi: 10.1186/s12905-023-02284-5. BMC Womens Health. 2023. PMID: 36973702 Free PMC article. Clinical Trial.

The intervention resulted in a significant reduction in the mean scores of both the VAS and VMS in the experimental group, in the first and second menstrual cycles (p < 0.001, p < 0.001, respectively), but not in the means score of PBLAC. Mefenamic acid consum

The intervention resulted in a significant reduction in the mean scores of both the VAS and VMS in the experimental group, in the first and …
Perichondritis.
Kadzombe EA, Robson WJ. Kadzombe EA, et al. Lancet. 1988 Oct 29;2(8618):1010-1. doi: 10.1016/s0140-6736(88)90755-6. Lancet. 1988. PMID: 2902441
An accurate history and a thorough examination are essential to reach the correct diagnosis. A short course of mefenamic acid was effective in all but one child, who responded to a local injection of methylprednisolone....
An accurate history and a thorough examination are essential to reach the correct diagnosis. A short course of mefenamic acid
Inflammasome, Inflammation, Infection and Mefenamic Acid.
Kasture P, Mehta K, Gowda A. Kasture P, et al. J Assoc Physicians India. 2022 Mar;70(3):11-12. J Assoc Physicians India. 2022. PMID: 35438288
The dysregulation of NLRP3 inflammasome can cause uncontrolled inflammation and drive the development of a wide variety of human diseases. Mefenamic acid which belongs to fenamate group inhibits the NLRP3 inflammasome by inhibiting efflux of chloride ions and influx …
The dysregulation of NLRP3 inflammasome can cause uncontrolled inflammation and drive the development of a wide variety of human diseases. …
Mefenamic acid overdosage.
Balali-Mood M, Critchley JA, Proudfoot AT, Prescott LF. Balali-Mood M, et al. Lancet. 1981 Jun 20;1(8234):1354-6. doi: 10.1016/s0140-6736(81)92528-9. Lancet. 1981. PMID: 6113321 No abstract available.
The potential and promise of mefenamic acid.
Cimolai N. Cimolai N. Expert Rev Clin Pharmacol. 2013 May;6(3):289-305. doi: 10.1586/ecp.13.15. Expert Rev Clin Pharmacol. 2013. PMID: 23656341 Review.
Clinical use of mefenamic acid has generally declined in an era where other NSAID use has flourished. While having modes of action and general toxicities similar to other NSAIDs, mefenamic acid, as a member of the fenamates, nevertheless possesses some …
Clinical use of mefenamic acid has generally declined in an era where other NSAID use has flourished. While having modes of ac …
Studies on Ponstan (mefenamic acid): I. Gastro-intestinal blood loss; II. Absorbtion and excretion of a new formulation.
Tall AR, Mistilis SP. Tall AR, et al. J Int Med Res. 1975;3(3):176-82. doi: 10.1177/030006057500300306. J Int Med Res. 1975. PMID: 162673
Using improved techniques in a study of faecal blood loss no significant change over control level occurred during administration of mefenamic acid 500 mg t.i.d. for six days. This lack of gastro-intestinal bleeding is at variance with earlier findings for this comp …
Using improved techniques in a study of faecal blood loss no significant change over control level occurred during administration of mefe
Mefenamic acid.
[No authors listed] [No authors listed] Br Med J. 1966 Dec 17;2(5528):1506-7. Br Med J. 1966. PMID: 5333309 Free PMC article. Clinical Trial. No abstract available.
1,895 results